| Citation: |
LIANG Yan. Interpretation on the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guidelines for the Management of Patients with Chronic Coronary Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 312-319. DOI: 10.12290/xhyxzz.2024-0043
|
| [1] |
Fihn S D, Gardin J M, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Associa-tion for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J]. Circulation, 2012, 126(25): e354-e471.
|
| [2] |
Fihn S D, Blankenship J C, Alexander K P, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J]. Circulation, 2014, 130(19): 1749-1767. DOI: 10.1161/CIR.0000000000000095
|
| [3] |
Virani S S, Newby L K, Arnold S V, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the manage-ment of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2023, 148(9): e9-e119.
|
| [4] |
Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J, 2020, 41(3): 407-477. DOI: 10.1093/eurheartj/ehz425
|
| [5] |
Patel K K, Spertus J A, Arnold S V, et al. Ischemia on PET MPI May identify patients with improvement in angina and health status post-revascularization[J]. J Am Coll Cardiol, 2019, 74(13): 1734-1736. DOI: 10.1016/j.jacc.2019.06.074
|
| [6] |
Patel K K, Spertus J A, Chan P S, et al. Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization[J]. Eur Heart J, 2020, 41(6): 759-768. DOI: 10.1093/eurheartj/ehz389
|
| [7] |
Heitner J F, Kim R J, Kim H W, et al. Prognostic value of vasodilator stress cardiac magnetic resonance imaging: a multicenter study with 48 000 patient-years of follow-up[J]. JAMA Cardiol, 2019, 4(3): 256-264. DOI: 10.1001/jamacardio.2019.0035
|
| [8] |
Kwong R Y, Ge Y, Steel K, et al. Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain[J]. J Am Coll Cardiol, 2019, 74(14): 1741-1755. DOI: 10.1016/j.jacc.2019.07.074
|
| [9] |
Al-Lamee R, Thompson D, Dehbi H M, et al. Percutane-ous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial[J]. Lancet, 2018, 391(10115): 31-40. DOI: 10.1016/S0140-6736(17)32714-9
|
| [10] |
REYNOLDS H R, SHAW L J, MIN J K, et al. Correction to: outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity[J]. Circulation, 2022, 146(1): 1024-1038.
|
| [11] |
Rees K, Takeda A, Martin N, et al. Mediterranean-style diet for the primary and secondary prevention of cardiova-scular disease[J]. Cochrane Database Syst Rev, 2019, 3(3): CD009825.
|
| [12] |
Tapsell L C, Neale E P. The effect of interdisciplinary interventions on risk factors for lifestyle disease: a literature review[J]. Health Educ Behav, 2016, 43(3): 271-285. DOI: 10.1177/1090198115601092
|
| [13] |
Hall K S, Hyde E T, Bassett D R, et al. Systematic review of the prospective association of daily step counts with risk of mortality, cardiovascular disease, and dysglycemia[J]. Int J Behav Nutr Phys Act, 2020, 17(1): 78. DOI: 10.1186/s12966-020-00978-9
|
| [14] |
Ference B A, Ginsberg H N, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel[J]. Eur Heart J, 2017, 38(32): 2459-2472. DOI: 10.1093/eurheartj/ehx144
|
| [15] |
Kosiborod M, Cavender M A, Fu A Z, et al. Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors)[J]. Circulation, 2017, 136(3): 249-259. DOI: 10.1161/CIRCULATIONAHA.117.029190
|
| [16] |
Sattar N, Lee M M Y, Kristensen S L, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials[J]. Lancet Diabetes Endocrinol, 2021, 9(10): 653-662. DOI: 10.1016/S2213-8587(21)00203-5
|
| [17] |
Yoshida Y, Cheng X, Shao H, et al. A systematic review of cost-effectiveness of sodium-glucose cotransporter inhibitors for type 2 diabetes[J]. Curr Diab Rep, 2020, 20(4): 12. DOI: 10.1007/s11892-020-1292-5
|
| [18] |
Gaziano J M, Brotons C, Coppolecchia R, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial[J]. Lancet, 2018, 392(10152): 1036-1046. DOI: 10.1016/S0140-6736(18)31924-X
|
| [19] |
Lopes R D, Hong H, Harskamp R E, et al. Optimal antithrombotic regimens for patients with atrial fibrillation undergoing percutaneous coronary intervention: an updated network meta-analysis[J]. JAMA Cardiol, 2020, 5(5): 582-589. DOI: 10.1001/jamacardio.2019.6175
|
| [20] |
Lopes R D, Hong H, Harskamp R E, et al. Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of randomized controlled trials[J]. JAMA Cardiol, 2019, 4(8): 747-755. DOI: 10.1001/jamacardio.2019.1880
|
| [21] |
Bonaca M P, Bhatt D L, Cohen M, et al. Long-term use of ticagrelor in patients with prior myocardial infarction[J]. N Engl J Med, 2015, 372(19): 1791-1800. DOI: 10.1056/NEJMoa1500857
|
| [22] |
Bhatt D L, Eikelboom J W, Connolly S J, et al. Role of combination antiplatelet and anticoagulation therapy in diabetes mellitus and cardiovascular disease: insights from the COMPASS trial[J]. Circulation, 2020, 141(23): 1841-1854. DOI: 10.1161/CIRCULATIONAHA.120.046448
|
| [23] |
Steffel J, Eikelboom J W, Anand S S, et al. The COMPASS trial: net clinical benefit of low-dose rivaroxaban plus aspirin as compared with aspirin in patients with chronic vascular disease[J]. Circulation, 2020, 142(1): 40-48. DOI: 10.1161/CIRCULATIONAHA.120.046048
|
| [24] |
Dargie H J. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the Capricorn randomised trial[J]. Lancet, 2001, 357(9266): 1385-1390. DOI: 10.1016/S0140-6736(00)04560-8
|
| [25] |
Park C S, Yang H M, Ki Y J, et al. Left ventricular ejection fraction 1 year after acute myocardial infarction identifies the benefits of the long-term use of β-blockers: analysis of data from the KAMIR-NIH registry[J]. Circ Cardiovasc Interv, 2021, 14(4): e010159. DOI: 10.1161/CIRCINTERVENTIONS.120.010159
|
| [26] |
Sorbets E, Steg P G, Young R, et al. β-Blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study[J]. Eur Heart J, 2019, 40(18): 1399-1407. DOI: 10.1093/eurheartj/ehy811
|
| [1] | JIN Di, NIE Weihua, REN Liying, SHEN Le. Research Progress on the Influence of Perioperative Sleep Quality on Postoperative Pain[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 897-903. DOI: 10.12290/xhyxzz.2023-0615 |
| [2] | TIAN Zhuang, ZHANG Shuyang. Interpretation on Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 801-806. DOI: 10.12290/xhyxzz.2024-0292 |
| [3] | XU Fen, ZHOU Zhou. Heart Failure: Prevention and Treatment are Indispensable[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 953-957. DOI: 10.12290/xhyxzz.2022-0440 |
| [4] | QIU Luhong, LIU Yingxian, XU Xiqi. Nonnegligible Myocarditis: Insights from 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 530-534. DOI: 10.12290/xhyxzz.2022-0077 |
| [5] | LU Fei, ZHANG Ning, KANG Lin, SUN Xiaohong, TIAN Ran, GUO Xiaoxiao, LIU Yongjian, ZHANG Wen, PENG Linyi, SU Tong, CAO Jian, WANG Yining, QIAN Min, CAO Yuze, YANG Lu, LIU Yuehua, ZHANG Lu, ZHAO Xiaoyi, LENG Ling. Decreased Muscle Strength, Type 2 Respiratory Failure, Heart Failure, Positive Anti-mitochondrial Antibodies—Rare Atypical Manifestations of Inflammatory Myopathy[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(1): 138-146. DOI: 10.12290/xhyxzz.2020-0109 |
| [6] | XU Fen, ZHOU Zhou. Universal Definition and Classification of Heart Failure Triggers the Standardization of Diagnosis and Treatment of Heart Failure[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 621-623. DOI: 10.12290/xhyxzz.2021-0436 |
| [7] | YU Jiren, WANG E, WANG Difen, CANG Jing, FENG Yi, ZHANG Xijing, YANG Yi, YANG Yunmei, WU Shuijing, WANG Weijian, DU Bin, SHANG You, LIN Ru, CHENG Baoli, XIE Guohao, FANG Xiangming. Expert Consensus on Perioperative Management of Elderly Septic Patients (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 481-489. DOI: 10.12290/xhyxzz.2021-0312 |
| [8] | CHEN Xiao-han, YU Qi. Protective Effect of Estrogen on Infection of Respiratory Virus[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(2): 179-183. DOI: 10.12290/xhyxzz.20200202 |
| [9] | Xiao-li XU, Xin SUI, Lan SONG, Yao HUANG, Xiao WANG, Zheng-yu JIN, Wei SONG. Imaging Manifestations of Respiratory Diseases Associated with Connective Tissue Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 79-84. DOI: 10.3969/j.issn.1674-9081.20180189 |
| [10] | Liang-liang ZHENG, Hua-dong ZHU, Jun XU, Ye-cheng LIU, Ji-hai LIU, Xue-zhong YU. Mechanical Ventilation Strategy in Pulmonary Fibrosis with Severe Respiratory Failure[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(3): 265-268. DOI: 10.3969/j.issn.1674-9081.2013.03.009 |
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: